Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DM3WRBQ)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Dibenzepin hydrochloride; Dibenzepine hydrochloride; Dibenzepine HCl; 315-80-0; Dibenzepin HCl; Noveryl; Noveril; Neodalit; Ansiopax; Dibenzepine monohydrochloride; UNII-JLN0273S4Z; Sedatiplex; Ecatril; JLN0273S4Z; Hydrofluoride-1927 wander; HF 1927; Dibenzepin hydrochloride [USAN]; EINECS 206-255-6; Ecatril hydrochloride; NSC 169412; DSSTox_RID_82755; DSSTox_CID_28394; DSSTox_GSID_48421; CAS-315-80-0; NSC169412; NCGC00160395-01; 10-(2-(Dimethylamino)ethyl)-5,10-dihydro-5-methyl-11-H-dibenzo(b,e)(1,4)diazepin-11-one monohydrochlorid
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||
|
|||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Hematopoietic system
Normal
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Hepatocellular carcinoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
